Inside Innovation

Scientists at Washington State University have created genetically engineered mice with short human-like telomeres that could help accelerate anti-aging research. “This is the first mouse

Institutions, biotech startups and life sciences companies are all conducting research and clinical trials that depend on federal grants and contracts. The lingering threat that

Marc Cummings, president and CEO of Life Science Washington, stresses that the life sciences industry values regulation to ensure the trustworthiness of new drugs. While

In less than 36 hours between the evening of Jan. 12 and the morning of Jan. 14, three local life science companies raised a combined

Washington Research Foundation (WRF) has awarded $93,030 over the next two years to support the training of Shoreline Community College (SCC) students working toward careers

Seattle-based Umoja Biopharma announced it raised $100 million in Series C funding earlier this month. Founded in 2019, Umoja develops in-body treatments to boost the

Truveta, a health data company based in Bellevue, Washington, announced $320 million in fresh funding to support an ambitious initiative to create a giant genomic

Tune Therapeutics, a biotech company with headquarters in Seattle and Durham, N.C., raised $175 million in one of the largest funding rounds for a Seattle-area

Absci, a drug discovery company based in Vancouver, Washington, secured a $20 million investment from Advanced Micro Devices (AMD) to integrate the company’s AI chips

Seattle-based Variant Bio announced a multi-year partnership with Novo Nordisk for using genomic information in treating metabolic diseases such as obesity and diabetes, totaling up

Researchers at Seattle’s Allen Institute for Brain Science have uncovered which cell types are most sensitive to aging, a discovery that could revolutionize the development

Research nonprofits Phenome Health and the Buck Institute have secured up to $52 million from the Advanced Research Projects Agency for Health. The funds will